|
|
|
 |
| A one-two punch targeting reactive oxygen species and fibril for rescuing Alzheimer’s disease |
| J. Wang,# P. Shangguan,# X. Chen, Y. Zhong, M. Lin, M. He, Y. Liu, Y. Zhou, X. Pang, L. Han, M. Lu, X. Wang, Y. Liu, H. Yang, J. Chen, Ch. Song, J. Zhang,* X. Wang,* B. Shi* & B. Z. Tang*. Nature Communications 2024, 15, 705.(IF=16.6) |
 |
| IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis |
| W. Lin,# R. Niu,# S.-M. Park,# Y. Zou,# S. S. Kim,# X. Xia, S. Xing, Q. Yang, X. Sun, Z. Yuan, S. Zhou, D. Zhang, H. Joon Kwon, S. Park, C. I. Kim, H. Koo, Y. Liu, H. Wu, M. Zheng, H. Yoo, B. Shi,* J. B. Park*, J. Yin*. Nature Communications 2023,14,1578. |
 |
| A Brain-Targeting NIR-II Ferroptosis System: Effective Visualization and Oncotherapy for Orthotopic Glioblastoma |
| J. Zhang, L. Han, H. Wu, Y. Zhong, P. Shangguan, Y. Liu, M. He, H. Sun, C. Song, X. Wang, Y. Liu, J. Wang,* L. Zheng,* B. Shi,* and B. Z. Tang*. Advanced Science. 2023, 2206333. (IF=17.521) |
 |
| Near-Infrared Aggregation-Induced Emission Luminogens for In Vivo Theranostics of Alzheimer’s Disease |
| T. Zhang,# X. Chen,# C. Yuan, X. Pang, Shangguan P., Y. Liu, L. Han, J. Sun, J. W. Y. Lam, Y. Liu, J. Wang,* B. Shi,* B. Z. Tang.* Angew. Chem. Int. Ed. 2022, e202211550. (IF=16.823) |
 |
| Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition |
| M. Ismail,# W. Yang,# Y. Li,# Y. Wang, W. He, J. Wang, P. Muhammad, T. B. Chaston, F. U. Rehman, M. Zheng, D. B. Lovejoy,* B. Shi.* Biomaterials 2022, 289, 121760 (IF=15.305) |
 |
| Brain-targeted CRISPR/Cas9 nanomedicine for effective glioblastoma therapy |
| W. Ruan,# M.Jiao,# S. Xu,# M. Ismail, X. Xie, Y. An, H. Guo, R. Qian,* B. Shi,* M. Zheng.* Journal of Controlled Release 2022, 351, 739–751 (IF=11.467) |
 |
| Arsenic Prodrug-Mediated Tumor Microenvironment Modulation Platform for Synergetic Glioblastoma Therapy |
| J. Yan,# S. Hanif,# D. Zhang, M. Ismail, X. Wang, Q. Li, B. Shi, P. Muhammad,* H. Wu.* ACS Applied Materials & Interfaces 2022, 14, 32, 36487–36502 (IF=10.383) |
 |
| Brain Codelivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy |
| Y. Zou,# Y. Wang,# S. Xu, Y. Liu, J. Yin, D. B. Lovejoy, M. Zheng, X-J Liang, J. B. Park, Y. M. Efremov, I. Ulasovand, B. Shi.* Advanced Materials 2022, 34, 2203958 (IF=32.085) |
 |
| Carbon dots supported single Fe atom nanozyme for drug-resistant glioblastoma therapy by activating autophagy-lysosome pathway |
| P. Muhammad,# S. Hanif,# J. Li, A. Guller, F. U. Rehman, M. Ismail, D. Zhang, X. Yan,* K. Fan,* B. Shi.* Nano Today 2022, 45, 101530 (IF=18.962) |
 |
| Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma |
| M. Ismail,# W. Yang,# Y. Li, T. Chai, D. Zhang, Q. Du, P. Muhammad, S. Hanif, M. Zheng,* B. Shi.* Biomaterials 2022, 287, 121608. (IF=15.305) |
 |
| Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy |
| Y. Zou,# X. Sun,# Q. Yang, M. Zheng,* O. Shimoni, W. Ruan, Y. Wang, D. Zhang, J. Yin, X. Huang, W. Tao, J. B. Park, X-J Liang, K. W. Leong, B. Shi.* Science Advances 2022, 8, eabm8011.（IF=14.98） |
 |
| Brain-targeted polymersome codelivery of siRNA and temozolomide for effective glioblastoma chemo-RNAi synergistic therapy |
| M. Zheng,# C. Yan,# Q. Yang, F. Zhu, Q. Du, X. Xia, M. Morsch, A. Lee, J. Yin, Y. Zou, B. Shi.* ChemPhysMater 2022, 1, 203–210. |
 |
| Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy |
| F. U. Rehman,# Y. Liu,# Q. Yang#, H. Yang, R. Liu, D. Zhang, P. Muhammad, Y. Liu, S. Hanif, M. Ismail, M. Zheng,* B. Shi.* Journal of Controlled Release 2022, 345,696–708.（IF=11.467） |
 |
| Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl‑1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy |
| W. He, X. Li, M. Morsch, M. Ismail, Y. Liu, F. U. Rehman, D. Zhang, Y. Wang, M. Zheng, R. Chung, Y. Zou,* and B. Shi.* ACS Nano 2022, 16, 6293−6308. （IF=18.028） |
 |
| Influence of Water and Enzyme on the Post-Transition State Bifurcation of NgnD-Catalyzed Ambimodal [6+4]/[4+2] Cycloaddition |
| X. Wang,# C. Zhang,# Y. Jiang, W. Wang, Y. Zhou, Y. Chen, B. Zhang, R. X. Tan, H. M. Ge,* Z. J. Yang,* and Y. Liang* Journal of the American Chemical Society. 2021, 143, 21003−21009. （IF=16.383） |
 |
| Brain-Targeted Aggregation-Induced-Emission Nanoparticles with Near-Infrared Imaging at 1550 nm Boosts Orthotopic Glioblastoma Theranostics |
| J. Wang, Y. Liu, M. Morsch, Y. Lu, P. Shangguan, L. Han, Z. Wang, X. Chen, C. Song, S. Liu,* B. Shi,* and B. Z. Tang*. Advanced Materials 2021, 2106082 (IF=32.085) |
 |
| Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy |
| T. Jiang, Y. Qiao, W. Ruan, D. Zhang, Q. Yang, G. Wang, Q. Chen, F. Zhu, J. Yin, Y. Zou, R. Qian, M. Zheng,* and B. Shi*. Advanced Materials. 2021, 2104779. (IF=32.085) |
 |
| Tuning the Elasticity of Polymersomes for Brain Tumor Targeting |
| M. Zheng#, Q. Du#, X. Wang, Y. Zhou, J. Li, X. Xia, Y. Lu, J. Yin, Y. Zou, J. B. Park, and B. Shi*. Advanced Science. 2021, 2102001 (IF=17.521) |
 |
| Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy |
| Y. Liu, M. Zheng*, M. Jiao, C. Yan, S. Xu, Q. Du, M. Morsch, J. Yin, B. Shi*. Biomaterials 2021, 276, 121036. (IF=15.305) |
 |
| Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer's disease therapy. |
| Y. Zhou#, F. Zhu#, Y. Liu#, M. Zheng*, Y. Wang, D. Zhang, Y. Anraku, Y. Zou, J. Li, H. Wu, X. Pang, W. Tao, O. Shimoni, A. I. Bush, X. Xue*, B. Shi*. Science Advances 2020, 6, eabc7031. (IF=14.98) |
 |
| A Robust Intrinsically Green Fluorescent Poly(Amidoamine) Dendrimer for Imaging and Traceable Central Nervous System Delivery in Zebrafish |
| G. Wang, X. Zhao, H. Wu, D. B. Lovejoy, M. Zheng, A. Lee, L. Fu, K. Miao, Y. An, N. Sayyadi, K. Ding, R. S. Chung, Y. Lu, J. Li,* M. Morsch,* and B. Shi*. Small. 2020, 2003654. (IF=15.154) |
 |
| ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages. |
| J. Yin*, S. Kim, E. Choi, Y. T. Oh, W. Lin, T-H Kim, J. K. Sa, J. H. Hong, S. H. Park, J. Lee, D-H Nam, K. S. Choi, B. Shi, H-S Gwak, H. Yoo, A. Iavarone*, J. H. Kim*, J. B. Park*. Nature Communications. 2020, 11: 2978 (IF=17.694) |
 |
| Stimuli-Responsive Prodrug-based Cancer Nanomedicine. |
| A. Xie#, S. Hanif#, O. Jiang*, Z. Tang, N. Kong, N. Y. Kim, B. Qia, B. Shi*, W. Tao*. EBioMedicine 2020, 56, 102821. (Invited Review) (IF=11.205) |
 |
| Evaluation of nanomechanical properties of hyperbranched polyglycerols as prospective cell membrane engineering block. |
| H. Wu#*, Q. Chen#, M. Jiao, X. Xia, X. Lian, N. Huang, K. Li, J. Yin, B. Shi*. Colloids and Surfaces B: Biointerfaces 2020, 190, 110968. (IF=5.999) |
 |
| Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy. |
| Y. Liu,# Y. Zou,# C. Feng,# A. Lee, J. Yin, R. Chung, J. B. Park, H. Rizos, W. Tao, M. Zheng,* O. C. Farokhzad,* B. Shi*. Nano Letters. 2020, 20, 1637–1646. (IF=11.189) |
 |
| SERS-based Nanostrategy for Rapid Anemia Diagnosis. |
| P. Muhammad#, S. Hanif#, J. Yan, F. U. Rehman, J. Wang, M. Khan, R. Chung, A. Lee, M. Zheng*, Y. Wang*, B. Shi*. Nanoscale. 2020, 12, 1948–1957. (IF=8.307) |
 |
| Central metal-derived co-assembly of biomimetic GdTPP/ZnTPP porphyrin nanocomposites for enhanced dual-modal imaging-guided photodynamic therapy. |
| J. Wang,# Z. Wang,# Y. Zhong, Y. Zou, C. Wang, H. Wu, A. Lee, W. Yang , X. Wang, Y. Liu, D. Zhang, J. Yan, M. Hao, M. Zheng, R. Chung, F. Bai,* B. Shi*. Biomaterials 2020, 229, 119576. (IF=15.305) |
 |
| ROS Responsive Polymeric siRNA Nanomedicine Stabilized by Triple-Interactions for the Robust Glioblastoma Combinational RNAi Therapy. |
| M. Zheng,# Y. Liu,# Y. Wang, D. Zhang, Y. Zou, W. Ruan, J. Yin, W. Tao, J. B. Park, and B. Shi*. Advanced Materials. 2019, 1903277.(IF=32.085) |
 |
| The siRNAsome: A Cation Free and Versatile Nanostructure for siRNA and Drug Codelivery. |
| M. Zheng,# T. Jiang,# W. Yang, Y. Zou, H. Wu, X. Liu, K. McDonald, D. Ling, J. Shi, F. Zhu, R. Qian and B. Shi*. Angewandte Chemie International Edition. 2019, 58, 4938–4942. (IF=16.823) |
 |
| Bioreducible Zinc(II)−Dipicolylamine Functionalized Hyaluronic Acid Mediates Safe siRNA Delivery and Effective Glioblastoma RNAi Therapy. |
| M. Zheng#, Z. Yang#, S. Chen#, H. Wu, Y. Liu, A. Wright, J. Lu, X. Xia, A. Lee, J. Zhang, H. Yin*, Y. Wang*, W. Ruan*, X. Liang. ACS Applied Bio Materials. 2019; 2: 362–369. |
 |
| Developing a pH-sensitive Al(OH)3 layer mediated UCNP@Al(OH)3/Au nanohybrids for photothermal therapy and fluorescence imaging in vivo. |
| J. Chen#, D. Zhang#, Y. Zou, Z. Wang, M. Hao, M. Zheng, X. Xue, X. Pan, Y. Lu, J. Wang*, B. Shi*. Journal of Materials Chemistry B. 2018; 6: 7862-7870. (IF=7.571) |
 |
| Stilbenes from Veratrum maackii Regel Protect against Ethanol-Induced DNA Damage in Mouse Cerebellum and Cerebral Cortex. |
| Y. Wu, S. Li, J. Liu, X. Liu, W. Ruan, J. Lu, Y. Liu, T. Lawson, O. Shimoni, D. B. Lovejoy, A. K. Walker, Y. Cong*, B. Shi*. ACS Chemical Neuroscience. 2018; 9(7): 1616-1624. (IF=5.78) |
 |
| Large-area gold nanohole arrays fabricated by one-step method for surface plasmon resonance biochemical sensing. |
| H. Qi, L. Niu, J. Zhang, J. Chen, S. Wang, J. Yang, S. Guo, T. Lawson, B. Shi*, C. Song*. Science China-Life Sciences. 2018; 61: 476-482. (invited paper, IF=10.385) |
 |
| DNA nanoclew templated spherical nucleic acid for siRNA delivery. |
| W. Ruan, M. Zheng*, Y. An, Y. Liu, D. Lovejoy, M. Hao, Y. Zou, A. Lee, S. Yang, Y. Lu, M. Morsch, R. Chung, B. Shi*. Chemical Communications. 2018; 54: 3609-3612.（IF=6.065） |
 |
| Stable upconversion nanohybrid particles for specific prostate cancer cell immunodetection. |
| Y. Shi, B. Shi*, A. V. E. Dass, Y. Lu, N. Sayyadi, L. Kautto, R. D. Willows, R. Chung, J. Piper, H. Nevalainen, B. Walsh, D. Jin, N. H. Packer. Scientific Reports. 2016; 6: 37533.(IF=4.997) |
 |
|
|
